Sales Support
U.S.:+1-415-871-0703
U.K.:+44-203-289-4040
JAPAN: +81-50-5539-1737
INDIA:+91-848-285-0837
Contact Us
We have an updated report [Version - 2023] available. Kindly sign up to get the sample of the report.
Healthcare and Pharmaceuticals industry

Sterile Injectables market 2020 BY MANUFACTURERS, REGIONS, TYPE AND APPLICATION, FORECAST TO 2026

  • Purchase Options

 
Report Description
The last decade has witnessed a major paradigm shift in the healthcare industry, with increasing inclination towards biologics over conventional drugs. Therapeutic areas such as Oncology, drugs are been overtaken by biologics as they are highly absorbable in the body with quick therapeutic response. Furthermore, the pharmaceutical industry too has been swept by winds of change, with strong biologics pipeline under their product portfolio. Novel drug delivery systems that deliver specific targeted therapies are gaining importance. These aspects, among others, have in turn led to a spike in growth of the sterile injectables market. Globally, around 2,400 injectables s are under development pipeline, which are potent and non-potent. This is a major factor directly fueling growth of the sterile injectables s market. The generic market is the largest target market for sterile injectables s. Major generics players such as Teva Pharmaceuticals, Hospira, Hikma, and Fresenius Kabi are also involved in development of sterile injectables s.
Market Dynamics
Accessibility of broader treatment therapy choice and growing prevalence of chronic illnesses prominently cancer globally is likely to fuel market demand for sterile injectables s over the forecast period. The high demand for sterile injectables is also driven by a large number of drug manufacturers/producers concentrating on developing drugs to treat cancer. Fast-track regulatory approvals of sterile injectables and minimization of approval timelines for innovative drug development to cure cancer is indirectly helping accelerate the drug supply and is significantly fueling growth of the global sterile injectables market. High operative costs and abrupt termination of injectables drugs for cancer treatment is expected to hamper revenue growth of the market across the globe. Manufacturing of sterile products necessitate the high end equipment for manufacturing and also the equipment needs regulatory certification and sterilization before production process. Hence, these activities lead to high operating costs and high debt levels. Furthermore, the FDA has stringent regulations pertaining to sterilization of drug and equipment, which further adds to the cost burden of the manufacturer as it entails maintaining a high degree of care in the manufacturing, packaging, storage, and distribution of sterile injectables drugs.
Market Taxonomy
This report segments the sterile injectables market on the basis of molecule type, drug type, application, end user, and geography. On the basis of molecule type, the market is categorized into large molecules and small molecules. On the basis of drug type, the market is categorized into Monoclonal Antibodies (mAbs), Cytokines, Insulin, Peptide Hormones, Vaccines, Immunoglobulins, Blood Factors, Peptide Antibiotics, and Others. On the basis of application, the market is categorized into Cancer, Diabetes, Cardiovascular Diseases, Central Nervous Systems, Infectious Disorders, Musculoskeletal and Others. On the basis of end user, the market is categorized into Hospitals, Drug Stores, Pharmacies and online pharmacies. For comprehensive understanding of market dynamics, the global sterile injectables market is analyzed across key geographical regions namely North America, Europe, Asia Pacific, Latin America, Africa, and Middle East. Each of these regions is analyzed on basis of market findings across major countries in these regions for a macro-level understanding of the market.
Key features of the study:
• This report provides in-depth analysis of the sterile injectables market which provides market size (US$ Billion) and Cumulative Annual Growth Rate (CAGR (%)) for the forecast period: 2016 - 2024, considering 2015 as the base year
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
• It profiles leading players in the global sterile injectables market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans
• Key companies covered as a part of this study include Baxter International Inc., AstraZeneca plc, Merck & Co., Inc., Novartis AG, and Johnson & Johnson Services, Inc.
• Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, end user upgrades, market expansion, and marketing tactics
• The global sterile injectables market report caters to various stakeholders in this industry, including investors, device/system manufacturers, distributors and suppliers for sterile injectables system, research and consulting firms, new entrants, and financial analysts
• Various strategy matrices used in analyzing the sterile injectables market would provide stakeholders vital inputs to make strategic decisions accordingly
Detailed Segmentation:
• Global Sterile Injectables Market, By Molecule Type :
o Large Molecules
o Small Molecules
• Global Sterile Injectables Market, By Drug Type :
o Monoclonal Antibodies (mAbs)
o Cytokines
o Insulin
o Peptide Hormones
o Vaccines
o Immunoglobulins
o Blood Factors
o Peptide Antibiotics
o Others
• Global Sterile Injectables Market, By Therapeutic Application:
o Cancer
o Diabetes
o Cardiovascular Diseases
o Central Nervous Systems
o Infectious Disorders
o Musculoskeletal
o Others
• Global Sterile Injectables Market, By End User:
o Hospitals
o Drug Stores
o Pharmacies
o Online Pharmacies
• Global Sterile Injectables Market, By Geography:
o North America
 U.S.
 U.S. Sterile Injectables Market, By Molecule Type:
 Large Molecules
 Small Molecules
 U.S. Sterile Injectables Market, By Drug Type:
 Monoclonal Antibodies (mAbs)
 Cytokines
 Insulin
 Peptide Hormones
 Vaccines
 Immunoglobulins
 Blood Factors
 Peptide Antibiotics
 Others
 U.S. Sterile Injectables Market, By Therapeutic Application:
 Cancer
 Diabetes
 Cardiovascular Diseases
 Central Nervous Systems
 Infectious Disorders
 Musculoskeletal
 Others
 U.S. Sterile Injectables Market, By End User:
 Hospitals
 Drug Stores
 Pharmacies
 Online Pharmacies
 Canada
 Canada Sterile Injectables Market, By Molecule Type:
 Large Molecules
 Small Molecules
 Canada Sterile Injectables Market, By Drug Type:
 Monoclonal Antibodies (mAbs)
 Cytokines
 Insulin
 Peptide Hormones
 Vaccines
 Immunoglobulins
 Blood Factors
 Peptide Antibiotics
 Others
 Canada Sterile Injectables Market, By Therapeutic Application:
 Cancer
 Diabetes
 Cardiovascular Diseases
 Central Nervous Systems
 Infectious Disorders
 Musculoskeletal
 Others
 Canada Sterile Injectables Market, By End User:
 Hospitals
 Drug Stores
 Pharmacies
 Online Pharmacies
o Europe
 U.K.
 U.K. Sterile Injectables Market, By Molecule Type:
 Large Molecules
 Small Molecules
 U.K. Sterile Injectables Market, By Drug Type:
 Monoclonal Antibodies (mAbs)
 Cytokines
 Insulin
 Peptide Hormones
 Vaccines
 Immunoglobulins
 Blood Factors
 Peptide Antibiotics
 Others
 U.K. Sterile Injectables Market, By Therapeutic Application:
 Cancer
 Diabetes
 Cardiovascular Diseases
 Central Nervous Systems
 Infectious Disorders
 Musculoskeletal
 Others
 U.K. Sterile Injectables Market, By End User:
 Hospitals
 Drug Stores
 Pharmacies
 Online Pharmacies
 Germany
 Germany Sterile Injectables Market, By Molecule Type:
 Large Molecules
 Small Molecules
 Germany Sterile Injectables Market, By Drug Type:
 Monoclonal Antibodies (mAbs)
 Cytokines
 Insulin
 Peptide Hormones
 Vaccines
 Immunoglobulins
 Blood Factors
 Peptide Antibiotics
 Others
 Germany Sterile Injectables Market, By Therapeutic Application:
 Cancer
 Diabetes
 Cardiovascular Diseases
 Central Nervous Systems
 Infectious Disorders
 Musculoskeletal
 Others
 Germany Sterile Injectables Market, By End User:
 Hospitals
 Drug Stores
 Pharmacies
 Online Pharmacies
 Italy
 Italy Sterile Injectables Market, By Molecule Type:
 Large Molecules
 Small Molecules
 Italy Sterile Injectables Market, By Drug Type:
 Monoclonal Antibodies (mAbs)
 Cytokines
 Insulin
 Peptide Hormones
 Vaccines
 Immunoglobulins
 Blood Factors
 Peptide Antibiotics
 Others
 Italy Sterile Injectables Market, By Therapeutic Application:
 Cancer
 Diabetes
 Cardiovascular Diseases
 Central Nervous Systems
 Infectious Disorders
 Musculoskeletal
 Others
 Italy Sterile Injectables Market, By End User:
 Hospitals
 Drug Stores
 Pharmacies
 Online Pharmacies
 France
 France Sterile Injectables Market, By Molecule Type:
 Large Molecules
 Small Molecules
 France Sterile Injectables Market, By Drug Type:
 Monoclonal Antibodies (mAbs)
 Cytokines
 Insulin
 Peptide Hormones
 Vaccines
 Immunoglobulins
 Blood Factors
 Peptide Antibiotics
 Others
 France Sterile Injectables Market, By Therapeutic Application:
 Cancer
 Diabetes
 Cardiovascular Diseases
 Central Nervous Systems
 Infectious Disorders
 Musculoskeletal
 Others
 France Sterile Injectables Market, By End User:
 Hospitals
 Drug Stores
 Pharmacies
 Online Pharmacies
 Spain
 Spain Sterile Injectables Market, By Molecule Type:
 Large Molecules
 Small Molecules
 Spain Sterile Injectables Market, By Drug Type:
 Monoclonal Antibodies (mAbs)
 Cytokines
 Insulin
 Peptide Hormones
 Vaccines
 Immunoglobulins
 Blood Factors
 Peptide Antibiotics
 Others
 Spain Sterile Injectables Market, By Therapeutic Application:
 Cancer
 Diabetes
 Cardiovascular Diseases
 Central Nervous Systems
 Infectious Disorders
 Musculoskeletal
 Others
 Spain Sterile Injectables Market, By End User:
 Hospitals
 Drug Stores
 Pharmacies
 Online Pharmacies
 Russia
 Russia Sterile Injectables Market, By Molecule Type:
 Large Molecules
 Small Molecules
 Russia Sterile Injectables Market, By Drug Type:
 Monoclonal Antibodies (mAbs)
 Cytokines
 Insulin
 Peptide Hormones
 Vaccines
 Immunoglobulins
 Blood Factors
 Peptide Antibiotics
 Others
 Russia Sterile Injectables Market, By Therapeutic Application:
 Cancer
 Diabetes
 Cardiovascular Diseases
 Central Nervous Systems
 Infectious Disorders
 Musculoskeletal
 Others
 Russia Sterile Injectables Market, By End User:
 Hospitals
 Drug Stores
 Pharmacies
 Online Pharmacies
 Rest of Europe
 Rest of Europe Sterile Injectables Market, By Molecule Type:
 Large Molecules
 Small Molecules
 Rest of Europe Sterile Injectables Market, By Drug Type:
 Monoclonal Antibodies (mAbs)
 Cytokines
 Insulin
 Peptide Hormones
 Vaccines
 Immunoglobulins
 Blood Factors
 Peptide Antibiotics
 Others
 Rest of Europe Sterile Injectables Market, By Therapeutic Application:
 Cancer
 Diabetes
 Cardiovascular Diseases
 Central Nervous Systems
 Infectious Disorders
 Musculoskeletal
 Others
 Rest of Europe Sterile Injectables Market, By End User:
 Hospitals
 Drug Stores
 Pharmacies
 Online Pharmacies
o Asia-Pacific
 China
 China Sterile Injectables Market, By Molecule Type:
 Large Molecules
 Small Molecules
 China Sterile Injectables Market, By Drug Type:
 Monoclonal Antibodies (mAbs)
 Cytokines
 Insulin
 Peptide Hormones
 Vaccines
 Immunoglobulins
 Blood Factors
 Peptide Antibiotics
 Others
 China Sterile Injectables Market, By Therapeutic Application:
 Cancer
 Diabetes
 Cardiovascular Diseases
 Central Nervous Systems
 Infectious Disorders
 Musculoskeletal
 Others
 China Sterile Injectables Market, By End User:
 Hospitals
 Drug Stores
 Pharmacies
 Online Pharmacies
 India
 India Sterile Injectables Market, By Molecule Type:
 Large Molecules
 Small Molecules
 India Sterile Injectables Market, By Drug Type:
 Monoclonal Antibodies (mAbs)
 Cytokines
 Insulin
 Peptide Hormones
 Vaccines
 Immunoglobulins
 Blood Factors
 Peptide Antibiotics
 Others
 India Sterile Injectables Market, By Therapeutic Application:
 Cancer
 Diabetes
 Cardiovascular Diseases
 Central Nervous Systems
 Infectious Disorders
 Musculoskeletal
 Others
 India Sterile Injectables Market, By End User:
 Hospitals
 Drug Stores
 Pharmacies
 Online Pharmacies
 Japan
 Japan Sterile Injectables Market, By Molecule Type:
 Large Molecules
 Small Molecules
 Japan Sterile Injectables Market, By Drug Type:
 Monoclonal Antibodies (mAbs)
 Cytokines
 Insulin
 Peptide Hormones
 Vaccines
 Immunoglobulins
 Blood Factors
 Peptide Antibiotics
 Others
 Japan Sterile Injectables Market, By Therapeutic Application:
 Cancer
 Diabetes
 Cardiovascular Diseases
 Central Nervous Systems
 Infectious Disorders
 Musculoskeletal
 Others
 Japan Sterile Injectables Market, By End User:
 Hospitals
 Drug Stores
 Pharmacies
 Online Pharmacies
 ASEAN
 ASEAN Sterile Injectables Market, By Molecule Type:
 Large Molecules
 Small Molecules
 ASEAN Sterile Injectables Market, By Drug Type:
 Monoclonal Antibodies (mAbs)
 Cytokines
 Insulin
 Peptide Hormones
 Vaccines
 Immunoglobulins
 Blood Factors
 Peptide Antibiotics
 Others
 ASEAN Sterile Injectables Market, By Therapeutic Application:
 Cancer
 Diabetes
 Cardiovascular Diseases
 Central Nervous Systems
 Infectious Disorders
 Musculoskeletal
 Others
 ASEAN Sterile Injectables Market, By End User:
 Hospitals
 Drug Stores
 Pharmacies
 Online Pharmacies
 Australia
 Australia Sterile Injectables Market, By Molecule Type:
 Large Molecules
 Small Molecules
 Australia Sterile Injectables Market, By Drug Type:
 Monoclonal Antibodies (mAbs)
 Cytokines
 Insulin
 Peptide Hormones
 Vaccines
 Immunoglobulins
 Blood Factors
 Peptide Antibiotics
 Others
 Australia Sterile Injectables Market, By Therapeutic Application:
 Cancer
 Diabetes
 Cardiovascular Diseases
 Central Nervous Systems
 Infectious Disorders
 Musculoskeletal
 Others
 Australia Sterile Injectables Market, By End User:
 Hospitals
 Drug Stores
 Pharmacies
 Online Pharmacies
 South Korea
 South Korea Sterile Injectables Market, By Molecule Type:
 Large Molecules
 Small Molecules
 South Korea Sterile Injectables Market, By Drug Type:
 Monoclonal Antibodies (mAbs)
 Cytokines
 Insulin
 Peptide Hormones
 Vaccines
 Immunoglobulins
 Blood Factors
 Peptide Antibiotics
 Others
 South Korea Sterile Injectables Market, By Therapeutic Application:
 Cancer
 Diabetes
 Cardiovascular Diseases
 Central Nervous Systems
 Infectious Disorders
 Musculoskeletal
 Others
 South Korea Sterile Injectables Market, By End User:
 Hospitals
 Drug Stores
 Pharmacies
 Online Pharmacies
 Rest of Asia Pacific
 Rest of Asia Pacific Sterile Injectables Market, By Molecule Type:
 Large Molecules
 Small Molecules
 Rest of Asia Pacific Sterile Injectables Market, By Drug Type:
 Monoclonal Antibodies (mAbs)
 Cytokines
 Insulin
 Peptide Hormones
 Vaccines
 Immunoglobulins
 Blood Factors
 Peptide Antibiotics
 Others
 Rest of Asia Pacific Sterile Injectables Market, By Therapeutic Application:
 Cancer
 Diabetes
 Cardiovascular Diseases
 Central Nervous Systems
 Infectious Disorders
 Musculoskeletal
 Others
 Rest of Asia Pacific Sterile Injectables Market, By End User:
 Hospitals
 Drug Stores
 Pharmacies
 Online Pharmacies
o Latin America
 Brazil
 Brazil Sterile Injectables Market, By Molecule Type:
 Large Molecules
 Small Molecules
 Brazil Sterile Injectables Market, By Drug Type:
 Monoclonal Antibodies (mAbs)
 Cytokines
 Insulin
 Peptide Hormones
 Vaccines
 Immunoglobulins
 Blood Factors
 Peptide Antibiotics
 Others
 Brazil Sterile Injectables Market, By Therapeutic Application:
 Cancer
 Diabetes
 Cardiovascular Diseases
 Central Nervous Systems
 Infectious Disorders
 Musculoskeletal
 Others
 Brazil Sterile Injectables Market, By End User:
 Hospitals
 Drug Stores
 Pharmacies
 Online Pharmacies
 Mexico
 Mexico Sterile Injectables Market, By Molecule Type:
 Large Molecules
 Small Molecules
 Mexico Sterile Injectables Market, By Drug Type:
 Monoclonal Antibodies (mAbs)
 Cytokines
 Insulin
 Peptide Hormones
 Vaccines
 Immunoglobulins
 Blood Factors
 Peptide Antibiotics
 Others
 Mexico Sterile Injectables Market, By Therapeutic Application:
 Cancer
 Diabetes
 Cardiovascular Diseases
 Central Nervous Systems
 Infectious Disorders
 Musculoskeletal
 Others
 Mexico Sterile Injectables Market, By End User:
 Hospitals
 Drug Stores
 Pharmacies
 Online Pharmacies
 Rest of Latin America
 Rest of Latin America Sterile Injectables Market, By Molecule Type:
 Large Molecules
 Small Molecules
 Rest of Latin America Sterile Injectables Market, By Drug Type:
 Monoclonal Antibodies (mAbs)
 Cytokines
 Insulin
 Peptide Hormones
 Vaccines
 Immunoglobulins
 Blood Factors
 Peptide Antibiotics
 Others
 Rest of Latin America Sterile Injectables Market, By Therapeutic Application:
 Cancer
 Diabetes
 Cardiovascular Diseases
 Central Nervous Systems
 Infectious Disorders
 Musculoskeletal
 Others
 Rest of Latin America Sterile Injectables Market, By End User:
 Hospitals
 Drug Stores
 Pharmacies
 Online Pharmacies
o Middle East
 GCC
 GCC Sterile Injectables Market, By Molecule Type:
 Large Molecules
 Small Molecules
 GCC Sterile Injectables Market, By Drug Type:
 Monoclonal Antibodies (mAbs)
 Cytokines
 Insulin
 Peptide Hormones
 Vaccines
 Immunoglobulins
 Blood Factors
 Peptide Antibiotics
 Others
 GCC Sterile Injectables Market, By Therapeutic Application:
 Cancer
 Diabetes
 Cardiovascular Diseases
 Central Nervous Systems
 Infectious Disorders
 Musculoskeletal
 Others
 GCC Sterile Injectables Market, By End User:
 Hospitals
 Drug Stores
 Pharmacies
 Online Pharmacies
 Israel
 Israel Sterile Injectables Market, By Molecule Type:
 Large Molecules
 Small Molecules
 Israel Sterile Injectables Market, By Drug Type:
 Monoclonal Antibodies (mAbs)
 Cytokines
 Insulin
 Peptide Hormones
 Vaccines
 Immunoglobulins
 Blood Factors
 Peptide Antibiotics
 Others
 Israel Sterile Injectables Market, By Therapeutic Application:
 Cancer
 Diabetes
 Cardiovascular Diseases
 Central Nervous Systems
 Infectious Disorders
 Musculoskeletal
 Others
 Israel Sterile Injectables Market, By End User:
 Hospitals
 Drug Stores
 Pharmacies
 Online Pharmacies
 Rest of Middle East
 Rest of Middle East Sterile Injectables Market, By Molecule Type:
 Large Molecules
 Small Molecules
 Rest of Middle East Sterile Injectables Market, By Drug Type:
 Monoclonal Antibodies (mAbs)
 Cytokines
 Insulin
 Peptide Hormones
 Vaccines
 Immunoglobulins
 Blood Factors
 Peptide Antibiotics
 Others
 Rest of Middle East Sterile Injectables Market, By Therapeutic Application:
 Cancer
 Diabetes
 Cardiovascular Diseases
 Central Nervous Systems
 Infectious Disorders
 Musculoskeletal
 Others
 Rest of Middle East Sterile Injectables Market, By End User:
 Hospitals
 Drug Stores
 Pharmacies
 Online Pharmacies
o Africa
 North Africa
 North Africa Sterile Injectables Market, By Molecule Type:
 Large Molecules
 Small Molecules
 North Africa Sterile Injectables Market, By Drug Type:
 Monoclonal Antibodies (mAbs)
 Cytokines
 Insulin
 Peptide Hormones
 Vaccines
 Immunoglobulins
 Blood Factors
 Peptide Antibiotics
 Others
 North Africa Sterile Injectables Market, By Therapeutic Application:
 Cancer
 Diabetes
 Cardiovascular Diseases
 Central Nervous Systems
 Infectious Disorders
 Musculoskeletal
 Others
 North Africa Sterile Injectables Market, By End User:
 Hospitals
 Drug Stores
 Pharmacies
 Online Pharmacies
 Central Africa
 Central Africa Sterile Injectables Market, By Molecule Type:
 Large Molecules
 Small Molecules
 Central Africa Sterile Injectables Market, By Drug Type:
 Monoclonal Antibodies (mAbs)
 Cytokines
 Insulin
 Peptide Hormones
 Vaccines
 Immunoglobulins
 Blood Factors
 Peptide Antibiotics
 Others
 Central Africa Sterile Injectables Market, By Therapeutic Application:
 Cancer
 Diabetes
 Cardiovascular Diseases
 Central Nervous Systems
 Infectious Disorders
 Musculoskeletal
 Others
 Central Africa Sterile Injectables Market, By End User:
 Hospitals
 Drug Stores
 Pharmacies
 Online Pharmacies
 South Africa
 South Africa Sterile Injectables Market, By Molecule Type:
 Large Molecules
 Small Molecules
 South Africa Sterile Injectables Market, By Drug Type:
 Monoclonal Antibodies (mAbs)
 Cytokines
 Insulin
 Peptide Hormones
 Vaccines
 Immunoglobulins
 Blood Factors
 Peptide Antibiotics
 Others
 South Africa Sterile Injectables Market, By Therapeutic Application:
 Cancer
 Diabetes
 Cardiovascular Diseases
 Central Nervous Systems
 Infectious Disorders
 Musculoskeletal
 Others
 South Africa Sterile Injectables Market, By End User:
 Hospitals
 Drug Stores
 Pharmacies
 Online Pharmacies
• Company Profiles
o Baxter International Inc.*
 Company Overview
 Product Portfolio
 Financial Performance
 Key Strategies
 Recent Developments
 Future Plans
o AstraZeneca plc
o Merck & Co., Inc
o Novartis AG
o Johnson & Johnson Services, Inc
"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents
1. Research Objective and assumption
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
? Market Definition and Scope
o Executive Summary
? Market Snippet By Molecule Type
? Market Snippet By Drug Type
? Market Snippet By Therapeutic Application
? Market Snippet By End User
? Market Snippet By Geography
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
? Drivers
? Supply Side Drivers
? Demand Side Drivers
? Economic Drivers
? Restraints
? Market Opportunities
o Industry Trend
o Mergers and Acquisitions
o Investments
o Porter's Five Force Analysis
o Pricing Analysis
4. Global Sterile Injectable Market, By Molecule Type, 2014 - 2024 (US$ Billion)
o Introduction
? Market Share Analysis, 2015 and 2024 (%)
? Y-O-Y Growth Analysis, 2014 - 2024
? Segment Trends
o Large Molecules
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Billion)
o Small Molecules
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Billion)
5. Global Sterile Injectable Market, By Drug Type, 2014 - 2024 (US$ Billion)
o Introduction
? Market Share Analysis, 2015 and 2024 (%)
? Y-O-Y Growth Analysis, 2014 - 2024
? Segment Trends
o Monoclonal Antibodies (mAbs)
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Billion)
o Cytokines
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Billion)
o Insulin
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Billion)
o Peptide Hormones
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Billion)
o Vaccines
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Billion)
o Immunoglobulins
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Billion)
o Blood Factors
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Billion)
o Peptide Antibiotics
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Billion)
o Others
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Billion)
6. Global Sterile Injectable Market, By Therapeutic Application, 2014 - 2024 (US$ Billion)
o Introduction
? Market Share Analysis, 2015 and 2024 (%)
? Y-O-Y Growth Analysis, 2014 - 2024
? Segment Trends
o Cancer
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Billion)
o Diabetes
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Billion)
o Cardiovascular Diseases
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Billion)
o Central Nervous Systems
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Billion)
o Infectious Disorders
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Billion)
o Musculoskeletal
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Billion)
o Others
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Billion)
7. Global Sterile Injectable Market, By End User, 2014 - 2024 (US$ Billion)
o Introduction
? Market Share Analysis, 2015 and 2024 (%)
? Y-O-Y Growth Analysis, 2014 - 2024
? Segment Trends
o Hospitals
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Billion)
o Drug Stores
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Billion)
o Pharmacies
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Billion)
o Online Pharmacies
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Billion)
8. Global Sterile Injectable Market, By Geography, 2014 - 2024 (US$ Billion)
o Introduction
? Market Share Analysis, By Region, 2015 and 2024 (%)
? Y-O-Y Growth Analysis, For Regions, 2014 - 2024
o North America
? Market Share Analysis, By Country, 2015 and 2024 (%)
? Y-O-Y Growth Analysis, By Country, 2014 - 2024
? U.S.
? Country Trends
? Market Size and Forecast, By Molecule Type, 2014 - 2024 (US$ Billion)
? Market Size and Forecast, By Drug Type, 2014 - 2024 (US$ Billion)
? Market Size and Forecast, By Therapeutic Application, 2014 - 2024 (US$ Billion)
? Market Size and Forecast, By End User, 2014 - 2024 (US$ Billion)
? Canada
? Country Trends
? Market Size and Forecast, By Molecule Type, 2014 - 2024 (US$ Billion)
? Market Size and Forecast, By Drug Type, 2014 - 2024 (US$ Billion)
? Market Size and Forecast, By Therapeutic Application, 2014 - 2024 (US$ Billion)
? Market Size and Forecast, By End User, 2014 - 2024 (US$ Billion)
o Europe
? Market Share Analysis, By Country, 2015 and 2024 (%)
? Y-O-Y Growth Analysis, By Country, 2014 - 2024
? U.K.
? Country Trends
? Market Size and Forecast, By Molecule Type, 2014 - 2024 (US$ Billion)
? Market Size and Forecast, By Drug Type, 2014 - 2024 (US$ Billion)
? Market Size and Forecast, By Therapeutic Application, 2014 - 2024 (US$ Billion)
? Market Size and Forecast, By End User, 2014 - 2024 (US$ Billion)
? Germany
? Country Trends
? Market Size and Forecast, By Molecule Type, 2014 - 2024 (US$ Billion)
? Market Size and Forecast, By Drug Type, 2014 - 2024 (US$ Billion)
? Market Size and Forecast, By Therapeutic Application, 2014 - 2024 (US$ Billion)
? Market Size and Forecast, By End User, 2014 - 2024 (US$ Billion)
? Italy
? Country Trends
? Market Size and Forecast, By Molecule Type, 2014 - 2024 (US$ Billion)
? Market Size and Forecast, By Drug Type, 2014 - 2024 (US$ Billion)
? Market Size and Forecast, By Therapeutic Application, 2014 - 2024 (US$ Billion)
? Market Size and Forecast, By End User, 2014 - 2024 (US$ Billion)
? France
? Country Trends
? Market Size and Forecast, By Molecule Type, 2014 - 2024 (US$ Billion)
? Market Size and Forecast, By Drug Type, 2014 - 2024 (US$ Billion)
? Market Size and Forecast, By Therapeutic Application, 2014 - 2024 (US$ Billion)
? Market Size and Forecast, By End User, 2014 - 2024 (US$ Billion)
? Spain
? Country Trends
? Market Size and Forecast, By Molecule Type, 2014 - 2024 (US$ Billion)
? Market Size and Forecast, By Drug Type, 2014 - 2024 (US$ Billion)
? Market Size and Forecast, By Therapeutic Application, 2014 - 2024 (US$ Billion)
? Market Size and Forecast, By End User, 2014 - 2024 (US$ Billion)
? Russia
? Country Trends
? Market Size and Forecast, By Molecule Type, 2014 - 2024 (US$ Billion)
? Market Size and Forecast, By Drug Type, 2014 - 2024 (US$ Billion)
? Market Size and Forecast, By Therapeutic Application, 2014 - 2024 (US$ Billion)
? Market Size and Forecast, By End User, 2014 - 2024 (US$ Billion)
? Rest of Europe
? Country Trends
? Market Size and Forecast, By Molecule Type, 2014 - 2024 (US$ Billion)
? Market Size and Forecast, By Drug Type, 2014 - 2024 (US$ Billion)
? Market Size and Forecast, By Therapeutic Application, 2014 - 2024 (US$ Billion)
? Market Size and Forecast, By End User, 2014 - 2024 (US$ Billion)
o Asia Pacific
? Market Share Analysis, By Country, 2015 and 2024 (%)
? Y-O-Y Growth Analysis, By Country, 2014 - 2024
? China
? Country Trends
? Market Size and Forecast, By Molecule Type, 2014 - 2024 (US$ Billion)
? Market Size and Forecast, By Drug Type, 2014 - 2024 (US$ Billion)
? Market Size and Forecast, By Therapeutic Application, 2014 - 2024 (US$ Billion)
? Market Size and Forecast, By End User, 2014 - 2024 (US$ Billion)
? India
? Country Trends
? Market Size and Forecast, By Molecule Type, 2014 - 2024 (US$ Billion)
? Market Size and Forecast, By Drug Type, 2014 - 2024 (US$ Billion)
? Market Size and Forecast, By Therapeutic Application, 2014 - 2024 (US$ Billion)
? Market Size and Forecast, By End User, 2014 - 2024 (US$ Billion)
? Japan
? Country Trends
? Market Size and Forecast, By Molecule Type, 2014 - 2024 (US$ Billion)
? Market Size and Forecast, By Drug Type, 2014 - 2024 (US$ Billion)
? Market Size and Forecast, By Therapeutic Application, 2014 - 2024 (US$ Billion)
? Market Size and Forecast, By End User, 2014 - 2024 (US$ Billion)
? ASEAN
? Country Trends
? Market Size and Forecast, By Molecule Type, 2014 - 2024 (US$ Billion)
? Market Size and Forecast, By Drug Type, 2014 - 2024 (US$ Billion)
? Market Size and Forecast, By Therapeutic Application, 2014 - 2024 (US$ Billion)
? Market Size and Forecast, By End User, 2014 - 2024 (US$ Billion)
? Australia
? Country Trends
? Market Size and Forecast, By Molecule Type, 2014 - 2024 (US$ Billion)
? Market Size and Forecast, By Drug Type, 2014 - 2024 (US$ Billion)
? Market Size and Forecast, By Therapeutic Application, 2014 - 2024 (US$ Billion)
? Market Size and Forecast, By End User, 2014 - 2024 (US$ Billion)
? South Korea
? Country Trends
? Market Size and Forecast, By Molecule Type, 2014 - 2024 (US$ Billion)
? Market Size and Forecast, By Drug Type, 2014 - 2024 (US$ Billion)
? Market Size and Forecast, By Therapeutic Application, 2014 - 2024 (US$ Billion)
? Market Size and Forecast, By End User, 2014 - 2024 (US$ Billion)
? Rest of Asia Pacific
? Country Trends
? Market Size and Forecast, By Molecule Type, 2014 - 2024 (US$ Billion)
? Market Size and Forecast, By Drug Type, 2014 - 2024 (US$ Billion)
? Market Size and Forecast, By Therapeutic Application, 2014 - 2024 (US$ Billion)
? Market Size and Forecast, By End User, 2014 - 2024 (US$ Billion)
o Latin America
? Market Share Analysis, By Country, 2015 and 2024 (%)
? Y-O-Y Growth Analysis, By Country, 2014 - 2024
? Brazil
? Country Trends
? Market Size and Forecast, By Molecule Type, 2014 - 2024 (US$ Billion)
? Market Size and Forecast, By Drug Type, 2014 - 2024 (US$ Billion)
? Market Size and Forecast, By Therapeutic Application, 2014 - 2024 (US$ Billion)
? Market Size and Forecast, By End User, 2014 - 2024 (US$ Billion)
? Mexico
? Country Trends
? Market Size and Forecast, By Molecule Type, 2014 - 2024 (US$ Billion)
? Market Size and Forecast, By Drug Type, 2014 - 2024 (US$ Billion)
? Market Size and Forecast, By Therapeutic Application, 2014 - 2024 (US$ Billion)
? Market Size and Forecast, By End User, 2014 - 2024 (US$ Billion)
? Argentina
? Country Trends
? Market Size and Forecast, By Molecule Type, 2014 - 2024 (US$ Billion)
? Market Size and Forecast, By Drug Type, 2014 - 2024 (US$ Billion)
? Market Size and Forecast, By Therapeutic Application, 2014 - 2024 (US$ Billion)
? Market Size and Forecast, By End User, 2014 - 2024 (US$ Billion)
? Rest of Latin America
? Country Trends
? Market Size and Forecast, By Molecule Type, 2014 - 2024 (US$ Billion)
? Market Size and Forecast, By Drug Type, 2014 - 2024 (US$ Billion)
? Market Size and Forecast, By Therapeutic Application, 2014 - 2024 (US$ Billion)
? Market Size and Forecast, By End User, 2014 - 2024 (US$ Billion)
o Middle East
? Market Share Analysis, By Country, 2015 and 2024 (%)
? Y-O-Y Growth Analysis, By Country, 2014 - 2024
? GCC Countries
? Country Trends
? Market Size and Forecast, By Molecule Type, 2014 - 2024 (US$ Billion)
? Market Size and Forecast, By Drug Type, 2014 - 2024 (US$ Billion)
? Market Size and Forecast, By Therapeutic Application, 2014 - 2024 (US$ Billion)
? Market Size and Forecast, By End User, 2014 - 2024 (US$ Billion)
? Israel
? Country Trends
? Market Size and Forecast, By Molecule Type, 2014 - 2024 (US$ Billion)
? Market Size and Forecast, By Drug Type, 2014 - 2024 (US$ Billion)
? Market Size and Forecast, By Therapeutic Application, 2014 - 2024 (US$ Billion)
? Market Size and Forecast, By End User, 2014 - 2024 (US$ Billion)
? Rest of Middle East
? Country Trends
? Market Size and Forecast, By Molecule Type, 2014 - 2024 (US$ Billion)
? Market Size and Forecast, By Drug Type, 2014 - 2024 (US$ Billion)
? Market Size and Forecast, By Therapeutic Application, 2014 - 2024 (US$ Billion)
? Market Size and Forecast, By End User, 2014 - 2024 (US$ Billion)
o Africa
? Market Share Analysis, By Country, 2015 and 2024 (%)
? Y-O-Y Growth Analysis, By Country, 2014 - 2024
? Northern Africa
? Country Trends
? Market Size and Forecast, By Molecule Type, 2014 - 2024 (US$ Billion)
? Market Size and Forecast, By Drug Type, 2014 - 2024 (US$ Billion)
? Market Size and Forecast, By Therapeutic Application, 2014 - 2024 (US$ Billion)
? Market Size and Forecast, By End User, 2014 - 2024 (US$ Billion)
? Central Africa
? Country Trends
? Market Size and Forecast, By Molecule Type, 2014 - 2024 (US$ Billion)
? Market Size and Forecast, By Drug Type, 2014 - 2024 (US$ Billion)
? Market Size and Forecast, By Therapeutic Application, 2014 - 2024 (US$ Billion)
? Market Size and Forecast, By End User, 2014 - 2024 (US$ Billion)
? South Africa
? Country Trends
? Market Size and Forecast, By Molecule Type, 2014 - 2024 (US$ Billion)
? Market Size and Forecast, By Drug Type, 2014 - 2024 (US$ Billion)
? Market Size and Forecast, By Therapeutic Application, 2014 - 2024 (US$ Billion)
? Market Size and Forecast, By End User, 2014 - 2024 (US$ Billion)
9. Competitive Landscape
o Heat Map Analysis
o Company Profiles
? Baxter International Inc.
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
? AstraZeneca plc,
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
? Merck & Co., Inc
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
? Novartis AG
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
? Johnson & Johnson Services, Inc
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
o Analyst Views
10. Section
o References
o Research Methodology
o About us and Sales Contact
*Browse 40 market data tables and 90 figures on "Sterile Injectable Market - Global forecast to 2024".
 

  • Purchase Options

  • Happy To Assist You

Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Mn Units).
Market is segmented by Product Types, Drug Class, Indication, Applications, Services Types, End-users, Distribution channel, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, pipeline Analysis, incidence rate, epidemiology analysis, prevalence rate, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, export-import analysis, trade analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Get In Touch

In search of customized market research solution? We are here to help you. Contact us.

Contact us